Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multi-center, international study

[1]  M. Tormo,et al.  Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy , 2020, Leukemia & lymphoma.

[2]  Tae Kon Kim,et al.  Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey* , 2018, Leukemia & lymphoma.

[3]  Sinyoung Kim,et al.  The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score‐matched study , 2018, Transfusion.

[4]  Bob Löwenberg,et al.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. , 2017, Blood.

[5]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[6]  H. Bag,et al.  Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience. , 2015, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[7]  G. Ehninger,et al.  How I treat hyperleukocytosis in acute myeloid leukemia. , 2015, Blood.

[8]  H. Kantarjian,et al.  Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis , 2015, British journal of haematology.

[9]  J. Beyene,et al.  Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis. , 2014, Leukemia research.

[10]  Kristine M. Thompson,et al.  Off-hour presentation and outcomes in patients with acute myocardial infarction: systematic review and meta-analysis , 2014, BMJ : British Medical Journal.

[11]  T. Hervig,et al.  Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia , 2013, Transfusion medicine.

[12]  M. Tallman,et al.  How I treat hematologic emergencies in adults with acute leukemia. , 2012, Blood.

[13]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[14]  D. Covas,et al.  Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia , 2011, Journal of clinical apheresis.

[15]  R. Hills,et al.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. , 2010, Blood.

[16]  Bob Löwenberg,et al.  Review Articles (434 articles) , 2008 .

[17]  K. Lee.  Off-Hour Admission and In-Hospital Stroke Case Fatality in the Get With The Guidelines-Stroke Program , 2010 .

[18]  Eric E. Smith,et al.  Off-Hour Admission and In-Hospital Stroke Case Fatality in the Get With The Guidelines-Stroke Program , 2009, Stroke.

[19]  A. Hagemeijer,et al.  Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  C. Pui,et al.  Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis , 2008, Cancer.

[21]  F. Ricci,et al.  Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. , 2008, Leukemia research.

[22]  T. Chao,et al.  Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: No impact on early mortality and intracranial hemorrhage , 2007, American journal of hematology.

[23]  E. Seifried,et al.  Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis , 2007, Transfusion.

[24]  I. Janszky,et al.  Weekend versus weekday admission and stroke outcome in Sweden from 1968 to 2005. , 2007, Stroke.

[25]  Alan C. Wilson,et al.  Weekend versus weekday admission and mortality from myocardial infarction. , 2007, The New England journal of medicine.

[26]  D. Horsman,et al.  Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia , 2006, Leukemia & lymphoma.

[27]  C. Bloomfield,et al.  Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Yu Shen,et al.  Leukapheresis Reduces Early Mortality in Patients with Acute Myeloid Leukemia with High White Cell Counts But Does Not Improve Long Term Survival , 2001, Leukemia & lymphoma.

[29]  X. Thomas,et al.  Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis , 2000, Annals of Hematology.

[30]  P. Porcu,et al.  Hyperleukocytic Leukemias and Leukostasis: A Review of Pathophysiology, Clinical Presentation and Management , 2000, Leukemia & lymphoma.

[31]  N. Heerema,et al.  Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate , 1997, British journal of haematology.